Polarean Imaging (POLX)

Sector:

Health Care

Index:

FTSE AIM All-Share

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

 15.88p
   
  • Change Today:
      0.000p
  • 52 Week High: 18.00
  • 52 Week Low: 13.75
  • Currency: UK Pounds
  • Shares Issued: 78.41m
  • Volume: 24,998
  • Market Cap: £12.45m

POLX Overview

Polarean is a clinical-stage company with a core technology that is a drug-device combination product that enables the visualisation of hyperpolarised 129Xe ("HPX") using MRI technology to help diagnose lung disease earlier, identify the type of intervention likely to benefit a patient, and to monitor the efficacy of treatment. It is currently being used at a number of research sites on a pre-FDA clearance basis to facilitate the research and evaluation of lung function, to assist in making improved disease progression assessment and to clearly visualise the effectiveness of several therapeutics which are under development.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -316.1% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 13.1 n/a
Pr/Book 4.7  
Latest F'cast
Revenue 40.9% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

POLX Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 0.88 (1.06) (99.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-17 1.24 (3.96) (371.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

POLX Company Announcements

Delivery of Xenon Polariser 03-Oct-2018 07:00 RNS
FIRST PATIENT IN PHASE III FDA CLINICAL TRIAL 23-Aug-2018 07:00 RNS
Half-year Report 22-Aug-2018 07:00 RNS

Latest POLX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

POLX Market Data

Currency UK Pounds
Share Price 15.88p
Change Today 0.000p
% Change 0.00 %
52 Week High 18.00
52 Week Low 13.75
Volume 24,998
Shares Issued 78.41m
Market Cap £12.45m

POLX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average
Income Not Available
Growth
Market averageMarket averageMarket averageMarket averageMarket average
35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average

POLX Dividends

No dividends found

Trades for 19-Oct-2018

Time Volume / Share Price
14:00 14,999 @ 16.20p
08:00 9,999 @ 16.10p

POLX Key Personnel

CEO Richard Hullihen
COO Kenneth West

Top of Page